Physicians in Brazil are implementing artificial intelligence algorithms to help assess oocytes, embryos, and pregnancy-related risks [1, 2].

This integration of machine learning into reproductive medicine arrives as more women seek to balance professional careers with motherhood. By automating the evaluation of reproductive cells, the technology aims to refine the decision-making process for doctors and patients during fertility treatments [2].

The systems focus on the analysis of oocytes and embryos, providing a data-driven layer to the traditional clinical observation process [1]. These algorithms are designed to identify specific markers and risks that may be difficult for the human eye to quantify consistently during the early stages of gestation [2].

Reproductive health providers are utilizing these tools to streamline the selection of the most viable embryos for implantation [1]. This approach reduces the reliance on subjective interpretation, a common challenge in embryology, and allows for a more standardized assessment of pregnancy risks [2].

The adoption of these tools reflects a broader trend of integrating AI into diagnostic medicine across South America. As the technology evolves, the goal is to increase the success rates of assisted reproduction and provide clearer prognostic data for expectant mothers [1, 2].

“AI algorithms are being introduced to assist doctors in evaluating eggs, embryos, and pregnancy risks.”

The shift toward AI-driven embryo selection represents a move from qualitative to quantitative reproductive medicine. By reducing human subjectivity in oocyte and embryo grading, these tools may increase the efficiency of IVF treatments and lower the risk of pregnancy complications, reflecting a systemic change in how maternal health is managed in Brazil.